Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
School of Pharmacy and Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
JAMA Cardiol. 2017 Jun 1;2(6):627-634. doi: 10.1001/jamacardio.2017.0491.
Trans-fatty acids (TFAs) have deleterious cardiovascular effects. Restrictions on their use were initiated in 11 New York State (NYS) counties between 2007 and 2011. The US Food and Drug Administration plans a nationwide restriction in 2018. Public health implications of TFA restrictions are not well understood.
To determine whether TFA restrictions in NYS counties were associated with fewer hospital admissions for myocardial infarction (MI) and stroke compared with NYS counties without restrictions.
DESIGN, SETTING, AND PARTICIPANTS: We conducted a retrospective observational pre-post study of residents in counties with TFA restrictions vs counties without restrictions from 2002 to 2013 using NYS Department of Health's Statewide Planning and Research Cooperative System and census population estimates. In this natural experiment, we included those residents who were hospitalized for MI or stroke. The data analysis was conducted from December 2014 through July 2016.
Residing in a county where TFAs were restricted.
The primary outcome was a composite of MI and stroke events based on primary discharge diagnostic codes from hospital admissions in NYS. Admission rates were calculated by year, age, sex, and county of residence. A difference-in-differences regression design was used to compare admission rates in populations with and without TFA restrictions. Restrictions were only implemented in highly urban counties, based on US Department of Agriculture Economic Research Service Urban Influence Codes. Nonrestriction counties of similar urbanicity were chosen to make a comparison population. Temporal trends and county characteristics were accounted for using fixed effects by county and year, as well as linear time trends by county. We adjusted for age, sex, and commuting between restriction and nonrestriction counties.
In 2006, the year before the first restrictions were implemented, there were 8.4 million adults (53.6% female) in highly urban counties with TFA restrictions and 3.3 million adults (52.3% female) in highly urban counties without restrictions. Twenty-five counties were included in the nonrestriction population and 11 in the restriction population. Three or more years after restriction implementation, the population with TFA restrictions experienced significant additional decline beyond temporal trends in MI and stroke events combined (-6.2%; 95% CI, -9.2% to -3.2%; P < .001) and MI (-7.8%; 95% CI, -12.7% to -2.8%; P = .002) and a nonsignificant decline in stroke (-3.6%; 95% CI, -7.6% to 0.4%; P = .08) compared with the nonrestriction populations.
The NYS populations with TFA restrictions experienced fewer cardiovascular events, beyond temporal trends, compared with those without restrictions.
反式脂肪酸(TFAs)对心血管有有害影响。2007 年至 2011 年间,纽约州(NYS)的 11 个县开始限制 TFA 的使用。美国食品和药物管理局计划在 2018 年在全国范围内实施限制。TFA 限制对公共卫生的影响还不太清楚。
确定纽约州有 TFA 限制的县与没有限制的县相比,因心肌梗死(MI)和中风住院的人数是否较少。
设计、地点和参与者:我们使用纽约州卫生署的全州规划和研究合作系统以及人口普查人口估计数,对 2002 年至 2013 年有 TFA 限制的县和没有限制的县的居民进行了回顾性观察性前后研究。在这个自然实验中,我们包括那些因 MI 或中风住院的居民。数据分析于 2014 年 12 月至 2016 年 7 月进行。
居住在 TFA 受到限制的县。
主要结果是基于 NYS 住院患者的主要出院诊断代码的 MI 和中风事件的综合。通过每年、年龄、性别和居住地计算入院率。采用差异-差异回归设计比较有和没有 TFA 限制的人群的入院率。限制仅在高度城市化的县实施,这是基于美国农业部经济研究局城市影响代码。选择了具有类似城市化程度的非限制县作为比较人群。通过县和年份的固定效应以及县的线性时间趋势来考虑时间趋势和县特征。我们调整了年龄、性别以及限制和非限制县之间的通勤。
在 2006 年,即第一个限制实施前的一年,有 TFA 限制的高度城市化县有 840 万成年人(53.6%为女性),而没有限制的高度城市化县有 330 万成年人(52.3%为女性)。有 25 个县被纳入非限制人群,11 个县被纳入限制人群。在限制实施三年或三年以上,限制 TFA 人群的 MI 和中风事件综合(-6.2%;95%CI,-9.2%至-3.2%;P<0.001)和 MI(-7.8%;95%CI,-12.7%至-2.8%;P=0.002)的发生出现了显著的额外下降,而中风的下降不显著(-3.6%;95%CI,-7.6%至 0.4%;P=0.08)与非限制人群相比。
与没有限制的人群相比,纽约州有 TFA 限制的人群经历了更少的心血管事件,超出了时间趋势。